[go: up one dir, main page]

NO300540B1 - Process for the preparation of 2-carboxy-3- [2- (dimethylamino) -ethyl] -N-methyl-1H-indole-5-methanesulfonamide and lower alkyl esters thereof and intermediate in the preparation - Google Patents

Process for the preparation of 2-carboxy-3- [2- (dimethylamino) -ethyl] -N-methyl-1H-indole-5-methanesulfonamide and lower alkyl esters thereof and intermediate in the preparation Download PDF

Info

Publication number
NO300540B1
NO300540B1 NO930394A NO930394A NO300540B1 NO 300540 B1 NO300540 B1 NO 300540B1 NO 930394 A NO930394 A NO 930394A NO 930394 A NO930394 A NO 930394A NO 300540 B1 NO300540 B1 NO 300540B1
Authority
NO
Norway
Prior art keywords
methyl
ethyl
indole
lower alkyl
methanesulfonamide
Prior art date
Application number
NO930394A
Other languages
Norwegian (no)
Other versions
NO930394L (en
NO930394D0 (en
Inventor
Pere Dalmases Barjoan
Francisco Marquillas Olondriz
Ana Bosch Rovira
Jose Maria Caldero Ges
Original Assignee
Vita Invest Sa
Sint Quimica Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Invest Sa, Sint Quimica Sa filed Critical Vita Invest Sa
Priority to NO930394A priority Critical patent/NO300540B1/en
Publication of NO930394D0 publication Critical patent/NO930394D0/en
Publication of NO930394L publication Critical patent/NO930394L/en
Publication of NO300540B1 publication Critical patent/NO300540B1/en

Links

Landscapes

  • Indole Compounds (AREA)

Description

Den foreliggende oppfinnelse vedrører en fremgangsmåte for fremstilling av 2-karboksy-3-[2-(dimetylamino)etyl]-N-metyl-lH-indol-5-metansulfonamid og laverealkylestere derav, tilsvarende den generelle formel I, og mellomprodukt tilsvarende formel III The present invention relates to a process for the production of 2-carboxy-3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulfonamide and lower alkyl esters thereof, corresponding to the general formula I, and intermediate product corresponding to formula III

hvor R kan være hydrogen eller laverealkyl. Disse syntetiske forbindelser finner anvendelse som syntesemellomprodukter for fremstilling av 3-[2-(dimetylamino)etyl-N-metyl-lH-indol-5-metansulfonamid, et produkt som har nyttige terapeutiske egenskaper ved behandling av migrene. where R can be hydrogen or lower alkyl. These synthetic compounds find use as synthesis intermediates for the production of 3-[2-(dimethylamino)ethyl-N-methyl-1H-indole-5-methanesulfonamide, a product which has useful therapeutic properties in the treatment of migraine.

Mellomproduktene for deres fremstilling samt fremgangsmåten, er ikke tidligere beskrevet. The intermediate products for their production as well as the method have not previously been described.

GB-patent nr. 1 189 064 (1968) beskriver fremstillingen av 2-karboalkoksy-3-(halogenetyl)indoler ved Fishers indolisering av de tilsvarende fenylhydrazoner i alkoholisk hydrogenklorid-mettet medium. Fremstillingen av fenylhydrazoner av a-keto-5-valerolakton ved omsetning av sistnevnte med det tilsvarende fenylhydrazin er beskrevet av J. Lehmann (Arch. Pharm., 320, 22-29 (1987)), og også i ovenfor refererte patent. GB Patent No. 1 189 064 (1968) describes the preparation of 2-carboalkoxy-3-(haloethyl)indoles by Fisher's indolisation of the corresponding phenylhydrazones in alcoholic hydrogen chloride-saturated medium. The production of phenylhydrazones from α-keto-5-valerolactone by reaction of the latter with the corresponding phenylhydrazine is described by J. Lehmann (Arch. Pharm., 320, 22-29 (1987)), and also in the above-referenced patent.

ES 523 039 beskriver fremstillingen av 4-hydrazino-N-metyl-benzenmetansulfonamid som er utgangsproduktet for den foreliggende oppfinnelse. ES 523 039 describes the production of 4-hydrazino-N-methyl-benzenemethanesulfonamide, which is the starting product for the present invention.

Det er hensiktene å frembringe fremgangsmåte til fremstilling av 2-karboksy-3-[2-(dimetylamino)etyl]-N-metyl-lH-indol-S-metansulf onamid og mellomprodukter i reaksjonen. The objectives are to produce a method for the production of 2-carboxy-3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-S-methanesulfonamide and intermediate products in the reaction.

Disse hensikter er oppnådd med foreliggende oppfinnelse kjennetegnet ved det som fremgår av kravene. These purposes have been achieved with the present invention characterized by what appears in the claims.

I den foreliggende oppfinnelse beskrives en fremgangsmåte for fremstilling av 2-karboksy-3-[2-dimetylamino)etyl-N-metyl-lH-indol-5-metansulfonamid (formel I) og dets laverealkylestere med den generelle formel II, hvori Alk er en laverealkylgruppe, fortrinnsvis metyl eller etyl. The present invention describes a process for the preparation of 2-carboxy-3-[2-dimethylamino)ethyl-N-methyl-1H-indole-5-methanesulfonamide (formula I) and its lower alkyl esters with the general formula II, in which Alk is a lower alkyl group, preferably methyl or ethyl.

De aktuelle forbindelser kan fremstilles fra forbindelsene med den generelle formel III The relevant compounds can be prepared from the compounds of the general formula III

i in

iin

hvor Alk er som definert for forbindelsene II, og X er en utgående gruppe såsom et halogenatom eller en mesyl- eller tosylgruppe, fortrinnsvis tosyl, ved å reagere dem med en where Alk is as defined for compounds II, and X is a leaving group such as a halogen atom or a mesyl or tosyl group, preferably tosyl, by reacting them with a

alkoholisk dimetylaminløsning ved en temperatur i området fra 0°C til 100°C, fortrinnsvis ca. 75°C. De fremstilte dimetyl-aminoestere II blir så renset ved ekstraksjon i et vandig medium og videre alkalisering. alcoholic dimethylamine solution at a temperature in the range from 0°C to 100°C, preferably approx. 75°C. The produced dimethyl amino esters II are then purified by extraction in an aqueous medium and further alkalization.

Dimetylaminosyren I fremstilles i sin tur ved forsåpning av dimetylaminoestrene II (Alk = Me eller Et) i alkalisk medium, f.eks. i en 5% etanolisk kaliumhydroksydløsning og ved en temperatur i området fra 20°C til 100°C, fortrinnsvis ved ca. 75°C. Produktet isoleres deretter på konvensjonell måte og renses videre ved omkrystallisering. The dimethylamino acid I is in turn produced by saponification of the dimethylamino esters II (Alk = Me or Et) in an alkaline medium, e.g. in a 5% ethanolic potassium hydroxide solution and at a temperature in the range from 20°C to 100°C, preferably at approx. 75°C. The product is then isolated in a conventional manner and further purified by recrystallization.

Forbindelsen III kan fremstilles etter følgende synteseskjerna. The compound III can be prepared according to the following synthesis principle.

Hydrazinhydrokloridet VI blir omsatt med a-keto-<S-valero-laktonet VII i vandig medium ved 70 °C og pH 2, ifølge fremgangsmåten beskrevet i litteraturen (se tidligere avsnitt), hvorved hydrazonet V blir fremstilt og isolert ved filtrering, idet ytterligere rensing ikke er nødvendig. The hydrazine hydrochloride VI is reacted with the α-keto-<S-valero-lactone VII in an aqueous medium at 70 °C and pH 2, according to the procedure described in the literature (see previous section), whereby the hydrazone V is prepared and isolated by filtration, while further Purification is not necessary.

Hydroksyesteren (IV), (f.eks. Alk = Me eller Et) fremstilles ved Fishers indolisering av hydrazonet V etterfulgt av transforestring i det samme reaksjonsmedium. Fremgangsmåten utføres i tørr hydrogenkloridløsning i den tilsvarende alkohol (f.eks. metanol eller etanol), ved en syrekonsentrasjon i området fra 3 N til 10 N, fortrinnsvis 5 N, i tilfelle etanol. Omsetningen kan gjennomføres ved en temperatur i området fra 0°c til 80°C, fortrinnsvis ved ca. 20°C. Produktet IV isoleres på konvensjonell måte, idet ytterligere rensing ikke er nødvendig. The hydroxyester (IV), (e.g. Alk = Me or Et) is prepared by Fisher's indolization of the hydrazone V followed by transesterification in the same reaction medium. The method is carried out in dry hydrogen chloride solution in the corresponding alcohol (e.g. methanol or ethanol), at an acid concentration in the range from 3 N to 10 N, preferably 5 N, in the case of ethanol. The reaction can be carried out at a temperature in the range from 0°C to 80°C, preferably at approx. 20°C. The product IV is isolated in a conventional manner, as further purification is not necessary.

Forbindelsen III fremstilles ut i fra hydroksyesteren IV ved substitusjon av hydroksygruppen med et halogenatom'ved anvendelse av konvensjonelle halogeneringsreagenser, eller ved omsetning med mesylklorid eller tosylklorid. The compound III is produced from the hydroxy ester IV by substitution of the hydroxy group with a halogen atom using conventional halogenation reagents, or by reaction with mesyl chloride or tosyl chloride.

Substitusjonsreaksjonen av den utgående gruppe fra forbindelsen III med dimetylamin foregår under spesielt milde betingelser i tilfelle tosylater. Nevnte forbindelse fremstilles hensikts-messig ved omsetning av hydroksyesteren IV med tosylklorid i nærvær av pyridin som løsningsmiddel og fra 5 til 10 molar, med hensyn til IV, av 4-dimetylaminopyridin som katalysator. Omsetningen kan utføres ved en temperatur fra 9°C til 50°C, fortrinnsvis ved ca. 20°C. The substitution reaction of the leaving group from compound III with dimethylamine takes place under particularly mild conditions in the case of tosylates. Said compound is conveniently prepared by reacting the hydroxyester IV with tosyl chloride in the presence of pyridine as solvent and from 5 to 10 molar, with respect to IV, of 4-dimethylaminopyridine as catalyst. The reaction can be carried out at a temperature from 9°C to 50°C, preferably at approx. 20°C.

Foreliggende fremgangsmåte viser oppfinnelseshøyde fordi en person med kunnskap på området ikke ville anvende forbindelsen i henhold til formel III (med -CH2-CH2-X i 3-posisjonen og med -COOEt i 2-posisjonen) for å oppnå forbindelser med formel II, siden overgangen fra forbindelse III til II bare er mulig ved behandling med dimetylamin. Reaksjonen med dimetylamin, med karboksyetylsubstituent i 2-posisjonen, ville ventes å gi et dimetylamid som et biprodukt av viktighet (II-amidprodukt i skjemaet under), fordi reaksjonen til aminacylering ved å bruke estere for å oppnå amider er godt beskrevet (Jerry March; Advanced Organic Chemistry, 2nd Ed., 386-387, McGraw-Hill). The present method shows inventive step because a person with knowledge in the field would not use the compound according to formula III (with -CH2-CH2-X in the 3-position and with -COOEt in the 2-position) to obtain compounds of formula II, since the transition from compound III to II is only possible by treatment with dimethylamine. The reaction with dimethylamine, with carboxyethyl substituent in the 2-position, would be expected to give a dimethylamide as a by-product of importance (II amide product in the scheme below), because the reaction of amine acylation using esters to obtain amides is well described (Jerry March; Advanced Organic Chemistry, 2nd Ed., 386-387, McGraw-Hill).

Reaktiviteten til aminene av en karbonylester eller laktonisk i 2-posisjonen til indol ble virkelig observert under utforsk-ningen av foreliggende oppfinnelse, når de anvendte betingelser var forskjellig fra de krevd i foreliggende søknad, i reaksjoner såsom: The reactivity of the amines of a carbonyl ester or lactonic in the 2-position of indole was indeed observed during the investigation of the present invention, when the conditions used were different from those required in the present application, in reactions such as:

Ikke desto mindre, og på tross av overskudd av dimetylamin anvendt, i konversjonen av forbindelse III til forbindelse II under betingelsene beskrevet i foreliggende patent, ble ikke dannelse av dimetylamidisk forbindelse med formel II-amid observert. Nevertheless, and despite the excess of dimethylamine used, in the conversion of compound III to compound II under the conditions described in the present patent, formation of the dimethylamidic compound of formula II amide was not observed.

BESKRIVELSE AV FORETRUKNE UTFØRELSER DESCRIPTION OF PREFERRED EMBODIMENTS

Eksempel 1: Fremstillin<g> av hydrazonet V Example 1: Preparation<g> of the hydrazone V

En løsning av 0,371 mol av ar-keto-5-valerolakton, fremstilt ved dekarboksylering av 69 g (0,371 mol) a-etoksy-allyl-r-butyro-lakton i 150 ml H2S04 oppvarmet til tilbakeløp, ble tilsatt dråpevis til en løsning på forhånd avkjølt til 5°C av 95 g A solution of 0.371 mol of ar-keto-5-valerolactone, prepared by decarboxylation of 69 g (0.371 mol) of α-ethoxy-allyl-r-butyrolactone in 150 mL of H 2 SO 4 heated to reflux, was added dropwise to a solution of pre-cooled to 5°C of 95 g

0,378 mol 4-hydrazin-N-metylbenzenmetansulfonamidhydroklorid og 19,4 g KOH i 600 ml vann. Etter at tilsetningen er fullstendig, justeres pH til 2 med 2 N vandig NaOH. Blandingen oppvarmes ved 60°C i 15 min. under kraftig omrøring, og får deretter oppnå 0.378 mol 4-hydrazine-N-methylbenzenemethanesulfonamide hydrochloride and 19.4 g KOH in 600 ml water. After the addition is complete, the pH is adjusted to 2 with 2 N aqueous NaOH. The mixture is heated at 60°C for 15 min. under vigorous stirring, and is then allowed to achieve

romtemperatur. Det dannes et blekgult bunnfall som frafiltreres og vaskes med vann. Det fremstilte faste stoff tørkes ved 45°C, hvorved det oppnås 111 g (96% med hensyn til hydrazin) av hydrazonet V. room temperature. A pale yellow precipitate is formed which is filtered off and washed with water. The solid produced is dried at 45°C, whereby 111 g (96% with respect to hydrazine) of the hydrazone V is obtained.

Smeltepunkt: 190-191°C Melting point: 190-191°C

IR (KBr), cm"<1>, 3419, 3309, 3277, 2947, 1690, 1614, IR (KBr), cm"<1>, 3419, 3309, 3277, 2947, 1690, 1614,

1582, 1529, 1387, 1308, 1250, 1152, 1582, 1529, 1387, 1308, 1250, 1152,

1124, 1073, 1052, 840, 578. 1124, 1073, 1052, 840, 578.

NMR (DMSO-d6), ppm: 1,65 (m, 2H; r-laktonprotoner) NMR (DMSO-d6), ppm: 1.65 (m, 2H; r-lactone protons)

2,55 (d J=7, 3H; CH3NH-) 2.55 (d J=7, 3H; CH3NH-)

3,45 (t J=7, 2H; fi-laktonprotoner) 3.45 (t J=7, 2H; fi-lactone protons)

4,10 (bredt signal, 2H; 5-laktonprotoner) 4.10 (broad signal, 2H; 5-lactone protons)

4,20 (s, 2H; -S02CH2-) 4.20 (s, 2H; -SO2CH2-)

6,85 (q, J=7, 1H; CH3NH-) 6.85 (q, J=7, 1H; CH3NH-)

7,30 (s, 4H; aromatisk) 7.30 (s, 4H; aromatic)

10,00 (s, 1H; -NH-N=) 10.00 (s, 1H; -NH-N=)

Analyse: C13<H>17<N>304S (M.W.: 311,36) Analysis: C13<H>17<N>304S (M.W.: 311.36)

Prosent beregnet: C 50,15; H 5,50; N 13,50; S 10,30 Percentage calculated: C 50.15; H 5.50; N 13.50; S 10.30

Prosent funnet: C 50,19; H 5,48; N 13,53; S 10,31 Percent found: C 50.19; H 5.48; N 13.53; S 10,31

Eksempel 2: Fremstilling av 2-karbetoksy-3-[2-hydroksyety1)-N-metyl- lH- indol- 5- metansulfonamid ( IV, Alk = Et) 70,0 g (0,255 mol) av hydrazinet V settes til 700 ml av en omrørt løsning av 10 N hydrogenklorid i vannfri etanol. Omrøring fortsettes ved romtemperatur i 1 time. Reaksjons-blandingen fortynnes med 700 ml vannfri etanol og omrøres i ytterligere 15 timer ved romtemperatur og helles deretter over 700 g is og bringes til pH 8-9 med fast vannfritt K2CO3. Etanolen destilleres av under vakuum, og resten ekstraheres fire ganger med 250 ml etylacetat hver gang. De samlete organiske sjikt vaskes med 250 ml mettet vandig natrium-kloridløsning og tørkes over vannfritt magnesiumsulfat. Løsningsmiddelet fordampes til tørrhet, hvorved det oppnås 47,4 g (62%) av produktet i form av et skum. Det rå produkt renses ved filtrering gjennom silikagel ved anvendelse av CH2Cl2/Ac=Et (1:1) som elueringsmiddel, etterfulgt av omkrystallisering fra etanol/vann. Example 2: Preparation of 2-carbethoxy-3-[2-hydroxyethyl)-N-methyl-1H-indole-5-methanesulfonamide (IV, Alk = Et) 70.0 g (0.255 mol) of the hydrazine V is added to 700 ml of a stirred solution of 10 N hydrogen chloride in anhydrous ethanol. Stirring is continued at room temperature for 1 hour. The reaction mixture is diluted with 700 ml of anhydrous ethanol and stirred for a further 15 hours at room temperature and then poured over 700 g of ice and brought to pH 8-9 with solid anhydrous K2CO3. The ethanol is distilled off under vacuum, and the residue is extracted four times with 250 ml of ethyl acetate each time. The collected organic layers are washed with 250 ml of saturated aqueous sodium chloride solution and dried over anhydrous magnesium sulfate. The solvent is evaporated to dryness, whereby 47.4 g (62%) of the product is obtained in the form of a foam. The crude product is purified by filtration through silica gel using CH2Cl2/Ac=Et (1:1) as eluent, followed by recrystallization from ethanol/water.

Smeltepunkt: 153,5-155,5°C. Melting point: 153.5-155.5°C.

IR (KBr), cm"<1>:3336, 2928, 1694, 1553, 1445, 1378, IR (KBr), cm"<1>:3336, 2928, 1694, 1553, 1445, 1378,

1317, 1253, 1155, 1119, 1090, 1040, 1317, 1253, 1155, 1119, 1090, 1040,

897, 846, 782, 531. 897, 846, 782, 531.

NMR (DMSO-d6), ppm:l,35 (t J=7, 3H; -COOCH2CH3) NMR (DMSO-d 6 ), ppm: 1.35 (t J=7, 3H; -COOCH 2 CH 3 )

2,55 (s, 3H; CH3NH-) 2.55 (s, 3H; CH3NH-)

3,25 (t J=7, 2H; -CH2CH2-OH) 3.25 (t J=7, 2H; -CH2CH2-OH)

5,55 (t J=7, 2H; -CH2CH2-OH) 5.55 (t J=7, 2H; -CH2CH2-OH)

4,29 (q J=7, 2H; -COOCH2CH3) 4.29 (q J=7, 2H; -COOCH2CH3)

4,31 (S, 1H; -OH) 4.31 (S, 1H; -OH)

4,35 (s, 2H; -S02CH2-) 4.35 (s, 2H; -SO2CH2-)

6,75 (bredt signal, 1H; CH3NH-) 6.75 (broad signal, 1H; CH3NH-)

7,3 0 (AB system J=8, 2H; aromatisk i C6 og C7) 7.3 0 (AB system J=8, 2H; aromatic in C6 and C7)

7,60 (s, 1H; aromatisk proton i C4) 7.60 (s, 1H; aromatic proton in C4)

13,2 (s, 1H; NH indol) 13.2 (s, 1H; NH indole)

Analyse: C15<H>20<N>2O5S (M.W.: 340,39) Analysis: C15<H>20<N>2O5S (M.W.: 340.39)

Prosent beregnet: C 52,93, H 5,92, N 8,23, S 9,42 Percentage calculated: C 52.93, H 5.92, N 8.23, S 9.42

Prosent funnet: C 52,97, H 5,90, N 8,26, S 9,39 Percent found: C 52.97, H 5.90, N 8.26, S 9.39

Eksempel 3: Fremstilling av 2-karbetoksy-3-(2-tosyloksyetyl)-N-metyl-lH-indol-5-metansulfonamid (III, Alk = Et, Example 3: Preparation of 2-carbethoxy-3-(2-tosyloxyethyl)-N-methyl-1H-indole-5-methanesulfonamide (III, Alk = Et,

X = OTS) X = OTS)

Til en omrørt løsning av 44,4 g (0,13 mol) av forbindelse IV (Alk - Et) i 256 ml pyridin tilsettes 38 g (1,5 ekviv.) tosylklorid og 1,7 g (0,1 ekviv.) 4-dimetylaminopyridin, og omrøringen fortsettes ved romtemperatur i 1 time. Reaksjons-blandingen helles over i 1 liter 3 N HCl-løsning på forhånd avkjølt til 0°C. Ekstraksjonen utføres med 3 x 400 ml diklor-metan. De samlete organiske sjikt vaskes i rekkefølge med mettet vandig natriumhydrogenkarbonat- og vandig natriumklorid-løsning. Etter tørking over vannfritt natriumsulfat blir løsningsmiddelet avdestillert til tørrhet, hvorved det oppnås 55 g (86%) av tosylatet av produkt III (Alk = Et) som et hvitt faststoff som eventuelt kan renses ytterligere ved filtrering på silikagel med CH2Cl2/AcOEt som elueringsmiddel. To a stirred solution of 44.4 g (0.13 mol) of compound IV (Alk - Et) in 256 ml of pyridine is added 38 g (1.5 equiv.) of tosyl chloride and 1.7 g (0.1 equiv.) 4-dimethylaminopyridine, and stirring is continued at room temperature for 1 hour. The reaction mixture is poured into 1 liter of 3 N HCl solution previously cooled to 0°C. The extraction is carried out with 3 x 400 ml of dichloromethane. The collected organic layers are washed sequentially with saturated aqueous sodium bicarbonate and aqueous sodium chloride solutions. After drying over anhydrous sodium sulfate, the solvent is distilled off to dryness, whereby 55 g (86%) of the tosylate of product III (Alk = Et) is obtained as a white solid which can optionally be further purified by filtration on silica gel with CH2Cl2/AcOEt as eluent.

Smeltepunkt: 130-131°C. Melting point: 130-131°C.

IR (KBr), cm_<1>:3301, 2968, 2960, 1545, 1358, 1316, IR (KBr), cm_<1>:3301, 2968, 2960, 1545, 1358, 1316,

1256, 1177, 1122, 1001, 949, 911, 783, 1256, 1177, 1122, 1001, 949, 911, 783,

662, 578, 554, 533. 662, 578, 554, 533.

NMR (CDC13), ppm:l,30 (t J=7, 3H; -COOCH2CH3) NMR (CDCl 3 ), ppm: 1.30 (t J=7.3H; -COOCH 2 CH 3 )

2,30 (s, 3H; CH3NH-) 2.30 (s, 3H; CH3NH-)

2,65 (s, 3H; CH3-Ph-S02-0-) 2.65 (s, 3H; CH3-Ph-SO2-0-)

3,32 (t J=8, 2H; -CH2CH2-OTs) 3.32 (t J=8, 2H; -CH2CH2-OTs)

4,00-4,60 (kompleks system, 6H; 4.00-4.60 (complex system, 6H;

-S02CH2-, -COOCH2CH3 V -SO2CH2-, -COOCH2CH3 V

-CH2CH2-OTs) -CH2CH2-OTs)

7,30 (AB system J=10, 4H, aromat 7.30 (AB system J=10, 4H, aromatic

fra tosylgruppen) from the tosyl group)

7,35 (AB system J=8, 2H, aromat 7.35 (AB system J=8, 2H, aromatic

i C6 og C7) in C6 and C7)

7,52 (s, 1H, aromat i C4) 7.52 (s, 1H, aromatic in C4)

9,05 (s, 1H, NH indol) 9.05 (s, 1H, NH indole)

Analyse: C22<H>26<N>2°7S2 (M.W.: 494,58) Analysis: C22<H>26<N>2°7S2 (M.W.: 494.58)

Prosent beregnet: C 53,43, H 5,30, N 5,66, S 12,96 Percentage calculated: C 53.43, H 5.30, N 5.66, S 12.96

Prosent funnet:C 53,39, H 5,33, N 5,61, S 13,00 Percent found: C 53.39, H 5.33, N 5.61, S 13.00

Eksempel 4: Fremstilling av 2-karbetoksy-3-[2-(dimetylamino)-etyl]-N-metyl-lH-indol-metansulfonamid fII. Alk = Et) Example 4: Preparation of 2-carbethoxy-3-[2-(dimethylamino)-ethyl]-N-methyl-1H-indole-methanesulfonamide fII. Alk = Et)

49,4 g (0,1 mol) av III (Alk = Et, X = OTs) løses i 200 ml av en 33% dimetylaminløsning i alkohol. Løsningen omrøres ved romtemperatur i 15 timer og oppvarmes deretter til tilbakeløp i løpet av 3 0 minutter. Løsningen inndampes til tørrhet, resten løses i 200 ml 3 N HC1 og vaskes med 3 x 80 ml CH2C12. Det vaskete vandige sjikt avkjøles, pH justeres til 12 med 10 N NaOH og ekstraheres med 3 x 100 ml CH2C12. De samlete organiske sjikt blir vasket med 100 ml mettet NaCl-løsning og tørket over vannfritt natriumsulfat. Løsningen inndampes til tørrhet, hvorved det oppnås 3 0 g (83%) av II (Alk = Et). Råproduktet omkrystalliseres fra etanol. 49.4 g (0.1 mol) of III (Alk = Et, X = OTs) are dissolved in 200 ml of a 33% dimethylamine solution in alcohol. The solution is stirred at room temperature for 15 hours and then heated to reflux within 30 minutes. The solution is evaporated to dryness, the residue is dissolved in 200 ml of 3 N HC1 and washed with 3 x 80 ml of CH2Cl2. The washed aqueous layer is cooled, the pH is adjusted to 12 with 10 N NaOH and extracted with 3 x 100 ml CH 2 Cl 2 . The collected organic layers are washed with 100 ml of saturated NaCl solution and dried over anhydrous sodium sulfate. The solution is evaporated to dryness, whereby 30 g (83%) of II (Alk = Et) are obtained. The crude product is recrystallized from ethanol.

Smeltepunkt: 153-155°C Melting point: 153-155°C

IR (KBr), cm~<1>:3343, 2945, 2790, 1674, 1545, 1446, IR (KBr), cm~<1>:3343, 2945, 2790, 1674, 1545, 1446,

1322, 1264, 1116, 1012, 781, 736. 1322, 1264, 1116, 1012, 781, 736.

NMR (CDC13), ppm:l,40 (t J=7, 3H; -COOCH2CH3) NMR (CDCl 3 ), ppm: 1.40 (t J=7.3H; -COOCH 2 CH 3 )

2,30 (S, 6H; -N(CH3)2) 2.30 (S, 6H; -N(CH3)2)

2,50 (m, 2H; -CH2CH2-N) 2.50 (m, 2H; -CH2CH2-N)

2,70 (s, 3H; CH3NH-) 2.70 (s, 3H; CH3NH-)

3,00 (m, 2H; -CH2CH2-N) 3.00 (m, 2H; -CH2CH2-N)

4,25 (s, 2H; -S02CH2-) 4.25 (s, 2H; -SO2CH2-)

4,30 (q, J=7, 2H; -COOCH2CH3) 4.30 (q, J=7, 2H; -COOCH2CH3)

7,25 (s, 2H; aromatisk i C6 og C7) 7.25 (s, 2H; aromatic at C6 and C7)

7,55 (s, 1H; aromatisk i C4) 7.55 (s, 1H; aromatic at C4)

9,30 (s, 1H; NH indol) 9.30 (s, 1H; NH indole)

Analyse: C17<H>25<N>304S (M.W.: 367,46) Analysis: C17<H>25<N>304S (M.W.: 367.46)

Prosent beregnet:C 55,57, H 6,86, N 11,44, S 8,72 Percentage calculated: C 55.57, H 6.86, N 11.44, S 8.72

Prosent funnet:C 56,00, H 6,90, N 11,41, S 8,69 Percent found: C 56.00, H 6.90, N 11.41, S 8.69

Eksempel 5: Fremstilling av 2-karboksy-3-[2-(dimetylamino)-etyl]- N- metyl- lH- indol- 5- metansulfonatom fl) Example 5: Preparation of 2-carboxy-3-[2-(dimethylamino)-ethyl]-N-methyl-1H-indole-5-methanesulfonatom fl)

14,3 g (0,04 mol) av II (Alk = Et) løses i 140 ml av en 5% KOH-løsning i etanol. Den resulterende løsning oppvarmes til tilbakeløp i 5 timer, avkjøles deretter og løsningsmiddelet destilleres av til tørrhet. Resten løses i 100 ml vann og vaskes med 3 x 70 ml CH2C12. Den vandige løsning avkjøles deretter til 5°C, og pH justeres til 6 med iseddiksyre. Omrøringen fortsettes ved 5°C i 1 time, og det utfelte faste stoff frafiltreres og tørkes ved 45°C, hvorved det oppnås 12,6 g (96%) av produkt I. 14.3 g (0.04 mol) of II (Alk = Et) are dissolved in 140 ml of a 5% KOH solution in ethanol. The resulting solution is heated to reflux for 5 hours, then cooled and the solvent distilled off to dryness. The residue is dissolved in 100 ml of water and washed with 3 x 70 ml of CH2C12. The aqueous solution is then cooled to 5°C, and the pH is adjusted to 6 with glacial acetic acid. Stirring is continued at 5°C for 1 hour, and the precipitated solid is filtered off and dried at 45°C, whereby 12.6 g (96%) of product I is obtained.

Smeltepunkt: 245-250°C (dek.) Melting point: 245-250°C (dec.)

IR (KBr), cm"<1>:3405, 3275, 1600, 1343, 1296, 1120, 972. IR (KBr), cm"<1>:3405, 3275, 1600, 1343, 1296, 1120, 972.

NMR (DMSO-d6), ppm:2,65 (bred singlet, 9H; CH3NH-, og NMR (DMSO-d6), ppm: 2.65 (broad singlet, 9H; CH3NH-, and

-N(CH3)2) -N(CH3)2)

3,05 (m, 2H; -CH2CH2-N) 3.05 (m, 2H; -CH2CH2-N)

3,35 (m, 2H; -CH2CH2-N) 3.35 (m, 2H; -CH2CH2-N)

4,35 (s, 2H; -S02CH2-) 4.35 (s, 2H; -SO2CH2-)

5,10 (bred singlet, 1H, aminosyreproton) 5.10 (broad singlet, 1H, amino acid proton)

6,85 (bredt signal, 1H; CH3NH-) 6.85 (broad signal, 1H; CH3NH-)

7,25 (AB system J=8, 2H, 7.25 (AB system J=8, 2H,

aromat i C6 og C7) aromatic in C6 and C7)

7,65 (s, 1H; aromatisk proton i C4) 7.65 (s, 1H; aromatic proton in C4)

12,15 (s, 1H; nH indol) 12.15 (s, 1H; nH indole)

Analyse: C15<H>21<N>3°4S (M.W.: 339,41) Analysis: C15<H>21<N>3°4S (M.W.: 339.41)

Prosent beregnet:C 53,08, H 6,24, N 12,38, S 9,45 Percentage calculated: C 53.08, H 6.24, N 12.38, S 9.45

Prosent funnet:C 53,10, H 6,28, N 12,36, S 9,44 Percent found: C 53.10, H 6.28, N 12.36, S 9.44

Claims (8)

1. Forbindelse, karakterisert ved at den tilsvarer formel III: ,l hvori ALK er en laverealkylgruppe, fortrinnsvis metyl eller etyl, og X er halogen, mesyl eller tosyl avspaltningsgruppe, fortrinnsvis en tosylavspaltningsgruppe.1. Connection, characterized in that it corresponds to formula III: ,l wherein ALK is a lower alkyl group, preferably methyl or ethyl, and X is halogen, mesyl or tosyl leaving group, preferably a tosyl leaving group. 2. Fremgangsmåte for fremstilling av 2-karboksy-3-[2-(dimetylamino)etyl]-N-metyl-lH-indol-5-metansulfonamid og laverealkylestere derav, karakterisert ved å omsette forbindelsen med den generelle formel III hvor Alk er en laverealkylgruppe og X er en utgående gruppe, med dimetylamin i nærvær av et egnet løsningsmiddel for å gi dimetylaminoesterforbindelsen med den generelle formel II som i sin tur, etter forsåpning, gir 2-karboksy-3-[2-(dimetyl-amino) etyl-N-metyl-lH-indol-5-metansulf onamid med formelen I2. Process for the production of 2-carboxy-3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulfonamide and lower alkyl esters thereof, characterized by reacting the compound with the general formula III where Alk is a lower alkyl group and X is a leaving group, with dimethylamine in the presence of a suitable solvent to give the dimethylaminoester compound of the general formula II which in turn, after saponification, gives 2-carboxy-3-[2-(dimethyl- amino) ethyl-N-methyl-1H-indole-5-methanesulfonamide of the formula I 3. Fremgangsmåte for fremstilling av 2-karboksy-3-[2-(dimetylamino)etyl]-N-metyl-lH-indol-5-metansulfonamid og laverealkylestere derav ifølge krav 2, karakterisert ved at det anvendes en laverealkylgruppe som fortrinnsvis er en metyl- eller en etylgruppe.3. Process for the production of 2-carboxy-3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulfonamide and lower alkyl esters thereof according to claim 2, characterized in that a lower alkyl group is used which is preferably a methyl or an ethyl group. 4. Fremgangsmåte for fremstilling av 2-karboksy-3-[2-(dimetylamino)etyl]-N-metyl-lH-indol-5-metansulfonamid og laverealkylestere derav ifølge krav 2 og 3, karakterisert ved at det anvendes en utgående gruppe som er et halogenatom, en mesyl- eller tosylgruppe, fortrinnsvis en tosylgruppe.4. Process for the production of 2-carboxy-3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulfonamide and lower alkyl esters thereof according to claims 2 and 3, characterized in that a leaving group is used which is a halogen atom, a mesyl or tosyl group, preferably a tosyl group. 5. Fremgangsmåte for fremstilling av 2-karboksy-3-[2-(dimetylamino)etyl]-N-metyl-lH-indol-5-metansulfonamid og laverealkylestere derav ifølge kravene 2-4, karakterisert ved' at forbindelsen med den generelle formel III blir omsatt med en dimetylaminløsning i et alkoholisk løsningsmiddel såsom metanol, etanol eller iso-propanol, fortrinnsvis etanol.5. Process for the production of 2-carboxy-3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulfonamide and lower alkyl esters thereof according to claims 2-4, characterized in that the compound of the general formula III is reacted with a dimethylamine solution in an alcoholic solvent such as methanol, ethanol or iso-propanol, preferably ethanol. 6. Fremgangsmåte for fremstilling av 2-karboksy-3-[2-(dimetylamino)etyl]-N-metyl-lH-indol-5-metansulfonamid og laverealkylestere derav ifølge kravene 2-5, karakterisert ved å gjennomføre omsetningen av forbindelsen III med dimetylamin ved en temperatur i området fra 0°C til 100°C, fortrinnsvis ved ca. 75°C.6. Process for the production of 2-carboxy-3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulfonamide and lower alkyl esters thereof according to claims 2-5, characterized by carrying out the reaction of the compound III with dimethylamine at a temperature in the range from 0°C to 100°C, preferably at approx. 75°C. 7. Fremgangsmåte for fremstilling av 2-karboksy-3-[2-(dimetylamino)etyl]-N-metyl-lH-indol-5-metansulfonamid og laverealkylestere derav ifølge kravene 2-6, karakterisert ved at forsåpningen av dimetylaminoesteren II gjennomføres i en alkoholisk eller hydro-alkoholisk alkalihydroksydløsning, fortrinnsvis i en 5% etanolisk kaliumhydroksydløsning.7. Process for the production of 2-carboxy-3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulfonamide and lower alkyl esters thereof according to claims 2-6, characterized in that the saponification of the dimethylaminoester II is carried out in an alcoholic or hydro-alcoholic alkali hydroxide solution, preferably in a 5% ethanolic potassium hydroxide solution. 8. Fremgangsmåte for fremstilling av 2-karboksy-3-[2-(dimetylamino)etyl]-N-metyl-lH-indol-5-metansulfonamid og laverealkylestere derav ifølge kravene 2-7, karakterisert ved at det anvendes forsåpning av dimetylaminoesteren II som gjennomføres ved en temperatur i området fra 20°C til 100°C, fortrinnsvis ved ca. 75°C.8. Process for the production of 2-carboxy-3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulfonamide and lower alkyl esters thereof according to claims 2-7, characterized in that saponification of the dimethylaminoester II is used which is carried out at a temperature in the range from 20°C to 100°C, preferably at approx. 75°C.
NO930394A 1993-02-04 1993-02-04 Process for the preparation of 2-carboxy-3- [2- (dimethylamino) -ethyl] -N-methyl-1H-indole-5-methanesulfonamide and lower alkyl esters thereof and intermediate in the preparation NO300540B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO930394A NO300540B1 (en) 1993-02-04 1993-02-04 Process for the preparation of 2-carboxy-3- [2- (dimethylamino) -ethyl] -N-methyl-1H-indole-5-methanesulfonamide and lower alkyl esters thereof and intermediate in the preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO930394A NO300540B1 (en) 1993-02-04 1993-02-04 Process for the preparation of 2-carboxy-3- [2- (dimethylamino) -ethyl] -N-methyl-1H-indole-5-methanesulfonamide and lower alkyl esters thereof and intermediate in the preparation

Publications (3)

Publication Number Publication Date
NO930394D0 NO930394D0 (en) 1993-02-04
NO930394L NO930394L (en) 1994-08-05
NO300540B1 true NO300540B1 (en) 1997-06-16

Family

ID=19895803

Family Applications (1)

Application Number Title Priority Date Filing Date
NO930394A NO300540B1 (en) 1993-02-04 1993-02-04 Process for the preparation of 2-carboxy-3- [2- (dimethylamino) -ethyl] -N-methyl-1H-indole-5-methanesulfonamide and lower alkyl esters thereof and intermediate in the preparation

Country Status (1)

Country Link
NO (1) NO300540B1 (en)

Also Published As

Publication number Publication date
NO930394L (en) 1994-08-05
NO930394D0 (en) 1993-02-04

Similar Documents

Publication Publication Date Title
US8969561B2 (en) Apixaban preparation process
US7563904B2 (en) Synthesis intermediates useful for preparing zolmitriptan
SK69695A3 (en) Process for preparing benzofuran compounds
US4814345A (en) 1-phenyl-2-aminocarbonylindole compounds, preparation thereof and pharmaceutical compositions containing them
EP2590947A1 (en) Intermediates and process for preparing a thrombin specific inhibitor
EP1527053B1 (en) Process for preparing rizatriptan
SU936813A3 (en) Process for producing derivatives of tetrahydropyridinylindole or their acid salts
NO164899B (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE IMIDAZOLYLINDOL COMPOUNDS.
NO300540B1 (en) Process for the preparation of 2-carboxy-3- [2- (dimethylamino) -ethyl] -N-methyl-1H-indole-5-methanesulfonamide and lower alkyl esters thereof and intermediate in the preparation
HRP20020471A2 (en) Process for the preparation of 6-methyl-2-(4-methyl-phenyl)-imidazo[1,2-a]pyrimidine-3-(n,n-dimethyl-acetamide) and intermediates
JPH03145468A (en) Production of carbostyryl derivative
RU2034842C1 (en) Quinoline derivative and a method of its synthesis
KR100280763B1 (en) Method for preparing 2-carboxy-3- [2- (dimethylamino) ethyl] -N-methyl-1H-indole-5-methanesulfonamide and lower alkyl esters thereof
US5175297A (en) Methyl-quinoline derivatives as mefloquin intermediates and process for preparation thereof
FI105095B (en) Process for the preparation of 2-carboxy-3- [2- (dimethylamino) ethyl] -N-methyl-1H-indole-5-methanesulfonamide and its lower alkyl esters
Bratton et al. Synthesis of novel 3‐and 5‐substituted indole‐2‐carboxamides
CZ283566B6 (en) Process for preparing 2-carboxy-3-[2-(dimethylamino)-ethyl] -n- methyl-1h-indole-5-methanesulfonamide and lower alkyl esters thereof
RU2108326C1 (en) Method of synthesis of 2-carboxy-3-[2-(dimethylamino)-ethyl]- -n-methyl-1h-indole-5-methane sulfoneamide
PL170341B1 (en) Method for the production of the new N-methyl- {2-carboxy-3- [2- (dimethylamino) ethyl] -1H-indolyl-5} metaesulfonamide and its gslrśw
SK280586B6 (en) Process for preparing 2-carboxy-3-[2-(dimethylamino)-ethyl]-n- -methyl-1h-indole-5-methanesulfonamide and lower alkyl esters thereof
US4543415A (en) Process for preparing tricyclic indoles
AT399871B (en) Process for the preparation of 2-carboxy-3-(2-(dimethyl amino)ethyl)-N-methyl-1H-indole-5-methanesulphonamide and its lower alkyl esters
JP3719269B2 (en) Process for producing 2-alkyl-4-oxo-5,6,7,8-tetrahydro-cycloheptimidazole
NO162019B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRIMIDOISKINOLIN DERIVATIVES.
WO2006010079A2 (en) Process for preparing naratriptan hydrochloride